# data[].attributes.headline
Step 2: Taxonomy of Enterococcus faecalis

# data[].attributes.subject
Step 2: Taxonomy of Enterococcus faecalis

# data[].attributes.body
Gemella Haemolysans is capable of causing severe infections and is an emerging bacterial etiology in Infective Endocarditis

# data[].attributes.attachment_link.readable_text
Abstract

An 87-year-old Caucasian woman with hypertension, diabetes mellitus type 2, and COPD was admitted with 1-week duration of back pain and weight gain. The physical examination revealed jugular venous distention, rales in the left lower lung field, and severe pitting edema over lower extremities. As workup for leukocytosis, blood cultures grew Gemella haemolysans. Subsequently, a transthoracic echocardiogram revealed vegetation on the non-coronary aortic leaflet and mild aortic stenosis. She was treated with ampicillin and gentamicin. After further investigation, the patient was diagnosed with plasma cell myeloma, the monoclonal lambda type. This is the first reported case of G. haemolysans endocarditis in a multiple myeloma patient.

Keywords: Gemella haemolysans, endocarditis, multiple myeloma, Gemella, antimicrobial therapy

Infective endocarditis (IE) is mostly caused by Gram-positive bacteria including Staphylococcus and Streptococcus. Gemella haemolysans is a Gram-positive coccoid, catalase-negative, facultative anaerobic microorganism of the mucus membranes in humans. However, G. haemolysans is able to cause severe and generalized infection as opportunistic pathogens, and it has become an emerging bacterial etiology in IE. Generally, Gemella endocarditis is associated with previous valvular damage or a poor dental state. Gemella endocarditis without preexistent valvular pathology has also been reported 1- 3. Here, we describe the first case of bacterial endocarditis caused by G. haemolysans in a newly diagnosed multiple myeloma patient.

Case report

An 87-year-old Caucasian female with a history of hypertension, atrial fibrillation (non-valvular) on Coumadin anticoagulation, diabetes mellitus type 2, and COPD was admitted to the hospital with severe back pain, right hip pain, and weight gain over 20 pounds over the past week. Patient also reported constipation due to the use of opiate. She denies fever and chills.

On admission, she was afebrile and the physical examination revealed jugular venous distention, few rales in left lower lung field, no wheezing, grade 2 systolic murmur at the aortic area radiating upward, and severe pitting edema over bilateral lower extremities. Laboratory studies disclosed the following data: WBC 8,690/mm ³ (10% bands, repeated WBC 11,730), Hb 10.5 g/dL, hematocrit 32.5%, platelet 162,000/mm ³, MCV 98, RDW 17.0, sodium 128 mEq/L, Cr 1.5 mg/dL, BUN 39 mg/dL, bicarbonate 21.7 mmol/L, pro BNP 4,841, total protein 10.6 g/dL, and albumin 3.2 g/dL. Chest radiography revealed pulmonary vascular congestion. ABG revealed pH 7.34, pO2 70, pCO ₂ 55, and SaO ₂ 92%. The initial treatment was targeted for heart failure and COPD exacerbation. We treated her with furosemide, short period of prednisone, and tiotropium bromide inhalation. Her hypoxia and edema improved and the Cr improved to 0.6 mg/dL.

As workup for leukocytosis, peripheral blood culture grew Gemella haemolysans in two cultures. Subsequently, transthoracic echocardiogram revealed LVEF 60-65%, mild aortic stenosis, and one small vegetation on the non-coronary aortic leaflet (); pulmonary artery pressure was 65 mmHg. We diagnosed infective endocarditis (IE), and we started ampicillin (2 g every 6 h) and gentamicin (100 mg daily, renal dosing) according to the sensitivities. Patient's blood cultures were negative twice before discharge. We continued both ampicillin and gentamicin for 4 weeks from the date of first negative blood culture.

We performed further investigations for source of infections. MRI of lumbar spine with contrast does not show any evidence of discitis, vertebral osteomyelitis, and epidural abscess, but mild T12 compression fracture. Abdominal and pelvic CT showed colon fecal impaction. Given the patient's age, anemia, back pain, and elevated gamma gap, we have the suspicion of plasma cell disorder. Patient's immunofixation electrophoresis showed an IgG lambda monoclonal protein comprising 39.9% of the total protein, equivalent to 3.8 mg/dL; therefore, we performed bone marrow aspiration and biopsy, which revealed plasma cell myeloma, monoclonal lambda type (35% of the cellular elements). Further skeletal survey did not find any abnormalities except the T12 compression fracture. Head CT showed cortical atrophy, without any bony changes. Patient was discharged with dexamethasone 20 mg weekly and antibiotics. Patient died unexpectedly 1 month later, no autopsy was performed.

Discussion

The members of Gemella species have been classified as G. morbillorum, G. haemolysans, G. bergeri, G. sanguinis, G. palaticanis, and G. cuniculi on the basis of DNA hybridization and comparative 16S rRNA gene sequencing ( 2). Infections due to G. haemolysans have been reported infrequently.

For the first time, Thjotta and Boe described G. haemolysans as Neisseria haemolysans in 1938 ( 4). Reyn et al. ( 5) showed that the structure of the cell wall of G. haemolysans was typical of Gram-positive cocci by electron microscopy. The comparative thinness (10-20 nm) of its cell wall accounts for easy decolorization during Gram staining. G. haemolysans may therefore appear as Gram-variable or even Gram-negative. It can be misidentified as a viridians streptococcus or remain unidentified.

G. haemolysans often colonizes in the upper respiratory, gastrointestinal, and genitourinary tract as a commensal organism and occasionally causes localized and/or disseminated infections. It is a rare cause of endocarditis, with 19 cases reported in the literature and only four cases associated with prosthetic valve endocarditis ( 1, 2, 3, 6). Our patient is the second case reported in the United States ( 7). Most documented cases of G. haemolysans endocarditis occur in patients with underlying mitral or aortic valve disease (including prosthetic valves) and/or poor dentition or dental manipulation, which was not the situation with this patient. Infected valves were aortic and mitral, both of them with the same percentage (50%) ( 1- 3). There are also case reports about meningitis ( 8) and brain abscess ( 9).

For diagnosing IE, there is generally good agreement between transthoracic echocardiography (TTE) and pathologic findings from autopsy or surgery. However, there are limitations in ultrasound measurements of small vegetations (<3 mm), which might be undetectable by TTE ( 10). Since our patient's vegetation size was 4-5 mm, and she was fragile, we defer the transesophageal echocardiography.

Antimicrobial therapy for G. haemolysans IE would typically include penicillin or ampicillin in combination with gentamicin. In all published cases, patients were successfully treated with antibiotics alone or in combination with cardiac valvular replacement, one patient with prosthetic valve endocarditis requiring implantation of a total artificial heart as a bridge to heart transplantation ( 6). The results of antimicrobial susceptibility studies by Buu-Hoï A ( 11) demonstrate that all strains of G. haemolysans were highly sensitive to penicillin G and ampicillin. Their results suggest that penicillin G combined with an aminoglycoside can be recommended for the treatment of endocarditis caused by G. haemolysans.

Patients with multiple myeloma are more susceptible to infections, which are the major causes of morbidity and mortality. Despite the common occurrence of bacteremia, IE is seldom reported. By searching PubMed, we can only find scattered case reports without statistic data about IE in multiple myeloma patients.

Conclusion

G. haemolysans is a rare but important cause of IE. The association of G. haemolysans and multiple myeloma has not been reported to date. Patients with multiple myeloma are susceptible to infection due to compromised immunoglobulin synthesis and function. In summary, because of the lack of other risk factors, we felt that multiple myeloma maybe a under recognized risk factor for endocarditis due to G. haemolysans.

Disclosure

None of the authors have any financial or personal bias that would inappropriately compromise the publication of this work.

Acknowledgements

The authors thank the Department of Pathology, Dr. Philip McDowell, Gail Shaw, and Division of Cardiology, Dr. Reed Riley for their continued support.

Conflict of interest and funding

The authors have not received any funding or benefits from industry or elsewhere to conduct this study.

References

4. Thjotta T, Boe J. [ Neisseria haemolysans. A hemolytic species of Neisseria trevisan . Acta Pathol Mirobiol Scand. 1938;(Suppl. 37):527-31. Google Scholar]

5. Reyn A, Birch-Andersen A, Berger U. Fine structure and taxonomic position of [ Neisseria haemolysans (Thjotta and Boe 1938) or Gemella haemolysans (Berger 1960) Acta Pathol Microbiol Scand Microbiol Immunol. 1970;78:375-89. [ PubMed] Google Scholar]

10. Gilbert BW, Haney RS, Crawford F. Two-dimensional echocardiographic assessment of vegetative endocarditis. Circulation. 1977;55:346. [[ PubMed] Google Scholar]

# data[].attributes.attachment_link.title
Endocarditis due to Gemella haemolysans in a newly diagnosed multiple myeloma patient

# data[].attributes.attachment_link.description
An 87-year-old Caucasian woman with hypertension, diabetes mellitus type 2, and COPD was admitted with 1-week duration of back pain and weight gain. The physical examination revealed jugular venous distention, rales in the left lower lung field, and severe ...

# data[].attributes.headline
Step 4: New Research for Gemella haemolysans from PubMed

# data[].attributes.subject
Step 4: New Research for Gemella haemolysans from PubMed

# data[].attributes.body
Gamella haemolysans causes subacute endocarditis, and from recent research penicillin G combined with an amino glycoside can be recommended for treatment for subacute endocarditis caused by Gemella haemolysans

# data[].attributes.attachment_link.readable_text
Abstract

Gemella haemolysans, a member of the family Streptococcacae, was isolated from patients with subacute endocarditis. The minimal inhibitory concentrations of 21 antimicrobial agents for five strains of the organism were determined. All strains were highly sensitive to penicillin G and ampicillin. Cefotaxime was the most active cephalosporin tested. All strains were sensitive to vancomycin, chloramphenicol and rifampin. Four strains were sensitive to tetracycline and erythromycin. All strains demonstrated a low level of resistance to aminoglycosides and were highly resistant to sulfonamides and trimethoprim. Killing curves and checker-board titration demonstrated synergism between penicillin G and streptomycin or gentamicin, and also between vancomycin and streptomycin or gentamicin. The results suggest that penicillin G combined with an aminoglycoside can be recommended for the treatment of subacute endocarditis caused by Gemella haemolysans.

Similar articles

Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.

Watanakunakorn C, Glotzbecker C. Watanakunakorn C, et al. J Med Microbiol. 1977 Feb;10(1):133-8. doi: 10.1099/00222615-10-1-133. J Med Microbiol. 1977. PMID: 584243

In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.

Skov R, Christensen JJ, Korner B, Frimodt-Møller N, Espersen F. Skov R, et al. J Antimicrob Chemother. 2001 Nov;48(5):653-8. doi: 10.1093/jac/48.5.653. J Antimicrob Chemother. 2001. PMID: 11679554

# data[].attributes.attachment_link.keywords[]
national center for biotechnology information

# data[].attributes.attachment_link.title
Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis - PubMed

# data[].attributes.attachment_link.description
Gemella haemolysans, a member of the family Streptococcacae, was isolated from patients with subacute endocarditis. The minimal inhibitory concentrations of 21 antimicrobial agents for five strains of the organism were determined. All strains were highly sensitive to penicillin G and ampicillin. Cef ...

# data[].attributes.headline
step 5: Organism 2 Source Page & Picture 

# data[].attributes.subject
step 5: Organism 2 Source Page & Picture 

# data[].attributes.body
- "Enterococcus faecalis is a gram-positive bacterium that can cause a variety of nosocomial infections of which urinary tract infections are the most common."
- Image below shows the light microscope evaluation of bladders & kidneys of mice infected with E. faecalis

# data[].attributes.attachment_link.readable_text
Abstract

Enterococcus faecalis is a gram-positive bacterium that can cause a variety of nosocomial infections of which urinary tract infections are the most common. These infections can be exceptionally difficult to treat because of drug resistance of many E. faecalis isolates. Despite their troublesome nature, little is known about the host or bacterial factors necessary for E. faecalis to cause disease in the urinary tract. Using a mouse model of urinary tract infection, we have shown that E. faecalis is capable of persisting in the kidneys of mice for at least 2 weeks. In contrast, bacterial titers from the bladders of the same mice were inconsistent and tended to be much lower than those recovered from the kidney. This preference for the kidney over the bladder is also observed in other clinical E. faecalis strains. Histologic examination of bladder and kidney tissues demonstrated that E. faecalis induced an inflammatory response in the kidney but not in the bladder. This inflammatory response was TLR2 independent and did not induce inflammatory markers typically associated with uropathogenic Escherichia coli. Using a competition assay, we demonstrated that a pyelonephritis clinical isolate had a growth advantage over a laboratory strain of E. faecalis in the kidneys but not in the bladders of mice. Taken together, these results demonstrate that E. faecalis has tropism for the kidneys in the urinary tracts of mice and that this system can be used to study factors involved in the pathogenesis of urinary tract infections.

Enterococcus faecalis, while normally a gut commensal, is a frequent cause of many serious human infections, including urinary tract infections, endocarditis, bacteremia, and wound infections. Among the diseases that E. faecalis causes, urinary tract infections are the most common, responsible for approximately 110,000 cases yearly, many of which are nosocomial. Infections with E. faecalis can be especially troublesome to treat because of their frequent resistance to multiple antibiotics, including vancomycin, a drug of last resort for many gram-positive infections (for a review, see reference 8).

Both rat and mouse model systems have been used to study factors involved in the pathogenesis of E. faecalis in the urinary tract. Studies by Guze and colleagues showed that E. faecalis has a growth advantage over other enterococcal species in rat kidneys in a hematogenous inoculation pyelonephritis model ( 18). Another model system was used to show that pyelonephritis caused by Pseudomonas aeruginosa was aggravated by coinfection with E. faecalis, as determined by histological changes in the kidney ( 30). In this model, ligation of the urethra was used to induce retrograde reflux of bacteria into the kidney, increasing the susceptibility of the mouse to infection. In a bladder catheterization model of urinary tract infection, the Esp (enterococcal surface protein) adhesin was found to increase persistence in the urinary bladder of mice, although no histological changes were observed ( 26). Another study was unable to demonstrate a critical function for aggregation substance, a well-characterized enterococcal adhesin, in a murine model of cystitis ( 12). Thus, a robust murine cystitis model of E. faecalis infection has yet to be established, most likely due to complicating host and bacterial factors reflecting the adaptations enterococcus has evolved to coexist with its host. In order to more effectively devise strategies and therapies to prevent and treat enterococcal urinary tract infections, an infection model that can give a sensitive readout of virulence factors must be developed.

In contrast, many of the host-pathogen interactions critical for bladder infections caused by uropathogenic Escherichia coli, the most common etiologic agent of urinary tract infections, have been well-defined in murine models. Uropathogenic E. coli initially interacts with bladder epithelium through the expression of type 1 pili, which mediate adhesion and invasion into the uroplakin-expressing umbrella cells on the surface of the bladder ( 19). The invasion of E. coli into the urinary epithelium results in expression of a variety of cytokines, induction of apoptosis in infected cells, and a massive neutrophil inflammatory response. This response is mediated primarily by Toll-like receptor 4, which has been demonstrated to respond to lipopolysaccharide ( 22, 23). The interaction of E. coli with the mouse kidney epithelium during pyelonephritis is less well characterized, but the importance of P pili is well established as an initial mediator of adherence in other animal models ( 21). Similar to bladder infections, acute E. coli-mediated pyelonephritis in mice is characterized by a strong neutrophil immune response ( 4).

In this study, we describe the tropism of E. faecalis for the kidneys in C57BL/6J mice. The consequences of this tropism were investigated by characterizing the host response to E. faecalis and contrasting these differences to the response induced by uropathogenic E. coli.

MATERIALS AND METHODS

Strains and growth conditions.

A summary of all the strains used in this study, their origins, and relevant drug resistances are shown in Table . For infection of mice, E. faecalis strains were grown statically overnight (typically 12 to 15 h) at 37°C in brain heart infusion (BHI) medium (Difco) without antibiotics. Clinical strains other than 0852 were contributed by Thomas Hooten and Walter Stamm (University of Washington) and categorized as either cystitis or pyelonephritis strains using clinical criteria.

TABLE 1.

Animals.

Female wild-type C57BL/6 mice were obtained from Jackson Laboratories and C57BL/6 TLR2 −/− mice were a gift of S. Akira ( 29). TLR2 −/− mice were 36 to 48 weeks in age at the time of inoculation. Wild-type 12-week-old and 52-week-old mice were used to control for the various ages of the TLR2 −/− mice. These experiments demonstrated that there was no substantial difference in the recoveries of E. faecalis due to the ages of the mice. In all other experiments, mice were 8 to 12 weeks of age.

Inoculation and CFU enumeration.

Cultures were collected by centrifugation at ≈6,000 × g for 10 min and resuspended in phosphate-buffered saline (PBS) to an approximate density of 10 ⁷ to 10 ⁸ CFU/ml. Female C57BL/6J mice were anesthetized with inhaled isoflurane and then inoculated transurethrally with 200 μl of bacterial suspension similar to methods described in Schilling et al. ( 23). Although the inoculation volume of 200 μl resulted in leakage during and after inoculation, we found that this volume resulted in the most consistent infections.

At the appropriate time points, mice were sacrificed by cervical dislocation after inhalation anesthesia and the bladders and kidneys were harvested. For histologic evaluation, tissue was fixed in neutral buffered formalin and embedded in paraffin. To determine the number of bacteria present in these tissues, bladders or pairs of kidneys were homogenized in 0.025% Triton X-100 in PBS and plated at different dilutions on BHI agar (BactoAgar from BD) supplemented with antibiotics where appropriate. CFU were enumerated after 24 h of incubation at 37°C. Statistical analysis of the kinetic experiment was performed using Student's one-tailed t test for correlated samples using the logarithmic values at each time point. When the recovered titers were below the limit of detection, the recovered CFU value was set to 1 for statistical analysis.

Immunohistochemistry.

For immunohistochemical analysis of bladder tissue, 5-μm-thick sections were prepared. Sections were deparaffinized using Hemo De (Fisher) (twice for 10 min), rinsed with isopropanol (three times for 3 min) and washed with PBS (three times for 5 min). Tissue sections were blocked with 1% bovine serum albumin, 0.2% nonfat dry milk, and 0.3% Triton X-100 in PBS (PBS-BB) for 15 min at room temperature. Primary antibody raised in rabbit against Streptococcus group D antigen (Lee Laboratories) was added in PBS-BB and incubated overnight at 4°C. After PBS washings (three times for 5 min), tissue was incubated with Alexafluor 555-labeled donkey anti-rabbit antibody (Molecular Probes) in PBS-BB and incubated overnight at 4°C. After PBS washes (three times for 5 min), tissue was counterstained with bis-benzimide (Sigma) to reveal nuclear morphology.

Quantitative real-time PCR.

Methods were as described in Mysorekar et al. ( 20) with the following modifications. Female C57BL/6J mice were inoculated transurethrally with 200 μl of PBS, E. faecalis 0852, or uropathogenic E. coli isolate NU14 grown statically in Luria-Bertani (LB) for 48 h to induce type 1 pilus expression. At the time of sacrifice, kidneys were divided lengthwise, and one half was harvested for RNA isolation and the other half was titered to confirm the presence of bacteria. RNA from infected bladders and kidneys was collected either 6 h or 24 h after infection individually from each mouse using a commercially available affinity matrix-based kit (RNeasy kits, Qiagen). cDNA was generated using random hexamers and quantitative real-time PCR was performed as described ( 20) using the Bio-Rad iCycler. Primers for amplification of glyceraldehhyde-3-phosphate dehydrogenase, Mip-2, and Socs-3 are as previously described ( 20).

Competitive infection.

Cultures of OG1X and BP78 were resuspended in PBS and mixed in equal volumes to make the mixed inoculum. The BP78 to OG1X ratio was determined by plating the mixed inoculum on medium selective for each strain; 48 h after infection, mice were sacrificed and their bladders and kidneys were collected and homogenized as described above. The homogenate was then plated onto either BHI agar supplemented with streptomycin, to select for OG1X, or tetracycline, to select for BP78. The competition index was calculated similarly to Freter et al. using OG1X as the reference strain ( 3). Briefly, the competition index = [(CFU of BP78/CFU of OG1X recovered from mice)/(CFU of BP78/CFU of OG1X present in initial inoculum)].

RESULTS

E. faecalis can cause a reproducible infection in C57BL/6J mouse kidneys.

In order to study E. faecalis cystitis, we inoculated 50 μl of 10 ⁸ CFU of an E. faecalis strain, 0852, from a diagnosed urinary tract infection transurethrally into female C57BL/6J mice. This protocol led to inconsistent recovery of bacteria from the bladder but noticeably higher titers in the kidney. Based on this observation, we used a 200-μl inoculum volume to intentionally induce retrograde reflux of the inoculum from the bladder into the kidney ( 11).

The ability of E. faecalis 0852 to persist in bladders and kidneys over a 2-week period is shown in Fig. . Fifteen minutes after inoculation, bacterial titers were high in both the bladder and the kidney. E. faecalis did not persist in the bladder, as bacterial titers decreased dramatically after 15 min, and many bladders were sterile at later time points. In contrast, recovery of bacteria from the kidneys remained steady over the first 12 h; 24 h after inoculation, bacterial levels in the kidney decreased but nevertheless persisted over a 2-week period. The conclusion from these studies was that E. faecalis persisted at higher titers in the kidney than in the bladder over a 2-week time frame (Fig. , P < 0.05 for five of nine time points, P < 0.1 for eight of nine time points).

The large dropoff in bladder titers between 15 min and 6 h was most likely due to the clearance of nonadherent bacteria from the bladder by mechanical forces of urine flow and other innate defenses. The persistence of E. faecalis in the kidneys over this time period indicated that the bacteria in the kidney were able to establish residence capable of evading innate defenses. Consistent with this hypothesis was the finding that 16% of mice had recoverable titers of 0852 in the kidneys despite having sterile bladders; conversely, no mice had recoverable bacterial titers in the bladder if their kidneys were sterile (Fig. , squares). Given the variability of CFU per bladder, we hypothesized that bacteria recovered from the bladder at later time points may represent bacteria shed from the kidney. Taken together, the persistence of 0852 in the kidney and its clearance from the bladder suggest that E. faecalis has tropism for the kidneys in the urinary tract of C57BL/6J mice.

Multiple E. faecalis clinical isolates display tropism for the kidney in the urinary tract of C57BL/6J mice.

To determine if the tropism of E. faecalis for the kidney in C57BL/6J mice is specific to strain 0852 or whether it represents a general feature of this species, we inoculated mice with five different strains of E. faecalis and harvested their bladders and kidneys for titers 48 h after infection (Fig. ). Two of these strains, B1223 and B1384, were cystitis isolates, and three others, P1503, BP78, and BP250, were pyelonephritis isolates. Consistent with what had been observed with 0852, all of the strains persisted in the kidney to higher levels than in the bladder. Only three mice of the 29 in the group infected with cystitis-derived isolates had more bacteria in the bladder than in the kidney. While this finding may represent an adaptation of the cystitis isolates to have increased adherence to bladder epithelium, the kidney still appeared to have the larger bacterial burden in the majority of mice.

Transurethral inoculation of 0852 results in inflammation in the kidneys but not the bladder.

Kidneys and bladders were subjected to histological analysis at various time points following inoculation with E. faecalis 0852. Hematoxylin and eosin staining revealed that there was little difference between infected and uninfected bladders at any of the time points examined (6 h, 24 h, 2 days, and 4 days; 24-h time point shown in Fig. ). In contrast, E. coli induces cystitis, as measured by the disruption of the bladder epithelium, marked edema, and recruitment of numerous neutrophils at the same time point ( 4, 14, 19).

Kidney sections from E. faecalis-infected mice, however, showed an inflammatory infiltrate in the renal pelvis. The inflammation was most consistently evident at 24 h after inoculation but was also seen at other time points as small, isolated collections of inflammatory cells. The level of inflammation at 24 h in the kidney was variable, sometimes appearing quite extensive, with inflammatory cells lining the entire pelvis (Fig. ), but small, localized patches of inflammation were also observed along the pelvis (as in Fig. ). The cellular infiltrate in the kidneys is primarily monocytic, as determined by histologic features. This is in contrast to the mostly neutrophilic infiltrate seen in E. coli pyelonephritis ( 4). The results of the histologic analysis of the bladder and kidney demonstrate that E. faecalis can consistently cause pathology in the kidney but not the bladder, further confirming the tropism of E. faecalis for the mouse kidney.

Immunohistochemistry was also utilized to demonstrate the presence of enterococcal antigen within the infected kidney. Using the rabbit Lancefield group D antibody, we showed staining in association with areas of inflammation at 24 h postinfection, demonstrating that the inflammatory cells were recruited in response to the presence of E. faecalis rather than damage to the kidney parenchyma by the inoculation procedure (Fig. ).

Inflammatory markers induced by uropathogenic E. coli are not upregulated in the bladder in response to E. faecalis.

The interaction of uropathogenic E. coli with the bladder epithelium results in the expression of a variety of proteins involved in epithelial renewal and immune function ( 20). Among these, the proinflammatory marker Mip-2, the mouse orthologue to human interleukin-8, and Socs-3, a modulator of cytokine induction, were highly upregulated. We investigated whether E. faecalis induced a similar response in the urinary tracts of mice.

E. faecalis 0852- or sham-infected mouse bladders and kidneys were harvested 6 h or 24 h after inoculation, and RNA was collected in order to quantify the relative levels of Mip-2 and Socs-3 by quantitative reverse transcription-PCR. The relative induction of Mip-2 and Socs-3 after infection with NU14 (a clinical uropathogenic E. coli isolate) or E. faecalis 0852 was investigated (Fig. ); 24 h after infection with either E. coli NU14 or E. faecalis 0852, NU14 induced Mip-2 and Socs-3 176-fold and 15-fold, respectively, over E. faecalis in the bladder. In the kidney, Mip-2 and Socs-3 were also more strongly induced by E. coli NU14 but not to the same magnitude (24-fold greater induction of Mip-2 and 4-fold greater induction of Socs-3 at 6 h, when the differences were most pronounced). Detection of focal inflammation in the kidney caused by E. faecalis may be diluted in this assay, which surveys gene expression levels of the whole kidney. Regardless, the observation that the uropathogenic E. coli strain NU14 was a more potent inducer of inflammatory mediators in both the bladder and kidneys implies a distinct pathogenic mechanism for E. faecalis in the urinary tract.

Innate response to E. faecalis in the kidneys is TLR2 independent.

TLR4 has been demonstrated to be an important mediator of the innate host response to E. coli urinary tract infections ( 22, 23). TLR2 has been shown to mediate the host innate response to some gram-positive constituents such as lipoteichoic acid and peptidoglycan ( 24, 31). To determine if TLR2 plays a role in the initial response to E. faecalis, TLR2-deficient C57BL/6 were inoculated with 0852, and kidney titers were compared to wild-type mice 24 h after inoculation. There was no observable difference between the TLR2-deficient mice and the wild-type mice 24 h after infection, indicating that TLR2 did not play a critical role in the innate response (Fig. ). Histologic examination of TLR2 and wild-type C57BL/6J mice revealed no observable difference in the levels of inflammation between wild-type and mutant mice (data not shown).

Clinically derived E. faecalis has a survival advantage over OG1X in the kidneys of mice.

To assess the utility of mouse kidney infections as a model system to study pathogenesis of E. faecalis, the clinical strain BP78 and the laboratory strain OG1X were inoculated either separately or in a mixed suspension. As shown in Fig. , OG1X and BP78 colonized the bladders and kidneys of mice equally well when infected separately, as determined 48 h after infection. However, in the mixed-infection model, BP78 showed a competitive advantage over OG1X of approximately 10-fold in the kidney, but there was no discernible difference in the bladder (Fig. ).

DISCUSSION

Enterococci are usually perceived as commensal bacteria that coexist with their host under most circumstances as part of the normal flora. While not regarded as particularly virulent organisms, enterococci can be significant agents of urinary tract infections in the hospital setting, where patients' defenses can be compromised by catheterization, immune deficiencies, or both. Given that E. faecalis is an opportunistic pathogen, animal model systems to study ascending urinary tract infections have been difficult to develop but will be essential for understanding the molecular basis of enterococcal disease.

Two recent studies used an ascending model of urinary tract infections similar to that used for uropathogenic E. coli to investigate the function of the Esp and aggregation substance adhesins in the pathogenesis of E. faecalis urinary tract infection. A role for aggregation substance has not yet been elucidated, whereas mutations in esp reduced colonization of the bladder. An interesting caveat in these studies was that approximately 30% of the mice had sterile bladders even when challenged with wild-type E. faecalis ( 12, 26). These results highlight the need to elucidate the host-pathogen interactions required to maintain robust urinary tract infections with enterococci. Interestingly, both studies noted significant colonization of the kidney tissue despite using a volume of inoculum designed to deliver bacteria only to the bladder.

In the present study, we discovered that E. faecalis has tropism for the kidneys in female C57BL/6J mice. This finding was made using a model where the inoculation volume of E. faecalis was increased in order to facilitate direct delivery of the bacteria to both the bladder and the kidneys simultaneously. Using this technique, we were able to recover bacteria from >90% of kidneys in mice infected with E. faecalis. In the same mice, the bladders were frequently sterile even though the kidneys were colonized. The molecular basis of this tropism for the kidney is unknown. Preferential adherence and/or invasion of E. faecalis to kidney versus bladder epithelium is a potential explanation, but host factors involved in innate defenses may also play a role.

The use of cultured bladder cells to study enterococcal pathogenesis in the urinary tract has limitations. Superficial umbrella cells lining the lumen of the bladder have specialized properties, including an ability to assemble uroplakins on their surface. Uroplakins form impermeable plaques that coat the luminal surface of the bladder ( 15). Cultured epithelial cells are not terminally differentiated, do not assemble uroplakins into plaques, and lack other distinguishing features of superficial umbrella cells, such as their large surface area and pentagonal shape ( 27). Thus, tropism is best studied in an animal model such as the one described here.

E. faecalis-mediated urinary tract infection appears to occur via a strikingly different mechanism than E. coli-mediated urinary tract infection. In a typical E. coli urinary tract infection, the bacteria invade the superficial umbrella cells and replicate to high levels, forming intracellular biofilms, a process that induces a TLR4-mediated cytokine response that recruits neutrophils to the site of infection ( 1, 22). In enterococcal urinary tract infection, there is little to no inflammation in the bladder. Furthermore, neutrophils represented only a minority of the inflammatory cells targeted to the site of infection, which typically is in the kidney. We found that TLR2, which is hypothesized to play a similar role in the innate response to gram-positives as TLR4 does for gram-negative pathogens ( 28, 29), does not play a substantial role in the innate response to E. faecalis in the urinary tract. Several observations reinforce this hypothesis. The presence or absence of TLR2 had no significant impact on the recovery of E. faecalis 24 h after infection. A luciferase reporter cell line expressing TLR2 was not stimulated by enterococci ( 32). Finally, there is substantial evidence that the host uses TLR2-independent pathways to stimulate inflammatory cascades in response to gram-positive infection ( 2, 5, 17). The recent discovery of TLR11, a Toll-like receptor that specifically recognizes uropathogens, suggested an additional innate mechanism used by the host to respond to enterococci ( 32).

All six E. faecalis strains tested in this study demonstrated the same tropism for the kidney, suggesting that most E. faecalis strains contain the core set of virulence factors necessary to cause disease in the kidney. When inoculated separately, OG1X, a commonly used laboratory strain of E. faecalis that lacks the recently described enterococcal pathogenicity island ( 25) and plasmid elements, and BP78, a clinical pyelonephritis isolate, persisted at similar levels over a 48-h period. This implies that OG1X has the essential molecular elements necessary to persist in the kidney. However, in a mixed-competition experiment, BP78 had a survival advantage of approximately 10-fold, suggesting that uropathogenic E. faecalis isolates have additional factors that lead to increased fitness in the urinary tract. Thus, mixed-infection experiments proved to be the most sensitive readout of additional virulence factors that enhance persistence in the kidney.

This work raises numerous questions related to human disease. The ability of enterococci to cause disease in the kidney is well established. The diagnosis of upper versus lower urinary tract infection caused by enterococci, as with gram-negative bacilli, is generally based on signs and symptoms. Thus, the presence of fever and flank pain, with or without lower tract symptoms of dysuria, frequency, and urgency suggest upper tract infection ( 13). Lower tract symptoms without upper tract symptoms are assumed to represent bladder infection, although it has been reported that about 30% of women with symptoms of bladder infection have silent upper tract infection ( 13). It will be important to determine whether the findings described in this work can be extended to humans. If enterococci have a strong tropism for the kidney, it is possible that many or most episodes of enterococcal cystitis are due to seeding from an upper tract infection. It is also possible that asymptomatic bacteriuria with enterococci is often localized to the upper tract rather than the bladder. The observation that enterococci fail to elicit a strong induction of inflammatory cytokines in our murine model is consistent with this hypothesis. If enterococcal urinary tract infections are often associated with upper tract infection, there may be treatment implications, since upper tract infection is usually treated for a longer duration than bladder infections ( 6).

Acknowledgments

We thank members of the Hultgren laboratory for reading the manuscript, T. Hooten and W. Stamm for providing clinical strains, and S. Akira for TLR2-deficient mice.

This work was supported by National Institutes of Health and Office of Research on Women's Health Specialized Center of Research P50DK6454002 with the Food and Drug Administration (to S.J.H.), NIH grant AI-38273 (M.G.C.), Individual National Research Service Award F32DK06388702 (to S.M.), Pediatric Physician-Scientist Training Grant 5T32HD4301003 (E.H.), and Medical Scientist Training Program grant T32 GM07200 (A.K.).

Notes

Editor: A. D. O'Brien

REFERENCES

3. [[ Freter, R., P. C. O'Brien, and M. S. Macsai. 1981. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect. Immun. 34 :234-240. PubMed] PMC free article] [ Google Scholar]

8. [[ Huycke, M. M., D. F. Sahm, and M. S. Gilmore. 1998. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4 :239-249. PubMed] PMC free article] [ Google Scholar]

9. [[ Ike, Y., D. B. Clewell, R. A. Segarra, and M. S. Gilmore. 1990. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn 917 insertional mutagenesis and cloning. J. Bacteriol. 172 :155-163. PubMed] PMC free article] [ Google Scholar]

17. [[ Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100 :1966-1971. PubMed] PMC free article] [ Google Scholar]

30. [[ Tsuchimori, N., R. Hayashi, A. Shino, T. Yamazaki, and K. Okonogi. 1994. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice. Infect. Immun. 62 :4534-4541. PubMed] PMC free article] [ Google Scholar]

# data[].attributes.attachment_link.title
Enterococcus faecalis Tropism for the Kidneys in the Urinary Tract of C57BL/6J Mice

# data[].attributes.attachment_link.description
Enterococcus faecalis is a gram-positive bacterium that can cause a variety of nosocomial infections of which urinary tract infections are the most common. These infections can be exceptionally difficult to treat because of drug resistance of many E. faecalis isolates. Despite their troublesome nature, little is known about the host or bacterial factors necessary for E.

# data[].attributes.headline
Step 6: Life style facts about organism 2

# data[].attributes.subject
Step 6: Life style facts about organism 2

# data[].attributes.body
Little is known for the reason as to why E. faecalis causes UTI's.

# data[].attributes.attachment_link.readable_text
Abstract

Enterococcus faecalis is a gram-positive bacterium that can cause a variety of nosocomial infections of which urinary tract infections are the most common. These infections can be exceptionally difficult to treat because of drug resistance of many E. faecalis isolates. Despite their troublesome nature, little is known about the host or bacterial factors necessary for E. faecalis to cause disease in the urinary tract. Using a mouse model of urinary tract infection, we have shown that E. faecalis is capable of persisting in the kidneys of mice for at least 2 weeks. In contrast, bacterial titers from the bladders of the same mice were inconsistent and tended to be much lower than those recovered from the kidney. This preference for the kidney over the bladder is also observed in other clinical E. faecalis strains. Histologic examination of bladder and kidney tissues demonstrated that E. faecalis induced an inflammatory response in the kidney but not in the bladder. This inflammatory response was TLR2 independent and did not induce inflammatory markers typically associated with uropathogenic Escherichia coli. Using a competition assay, we demonstrated that a pyelonephritis clinical isolate had a growth advantage over a laboratory strain of E. faecalis in the kidneys but not in the bladders of mice. Taken together, these results demonstrate that E. faecalis has tropism for the kidneys in the urinary tracts of mice and that this system can be used to study factors involved in the pathogenesis of urinary tract infections.

Enterococcus faecalis, while normally a gut commensal, is a frequent cause of many serious human infections, including urinary tract infections, endocarditis, bacteremia, and wound infections. Among the diseases that E. faecalis causes, urinary tract infections are the most common, responsible for approximately 110,000 cases yearly, many of which are nosocomial. Infections with E. faecalis can be especially troublesome to treat because of their frequent resistance to multiple antibiotics, including vancomycin, a drug of last resort for many gram-positive infections (for a review, see reference 8).

Both rat and mouse model systems have been used to study factors involved in the pathogenesis of E. faecalis in the urinary tract. Studies by Guze and colleagues showed that E. faecalis has a growth advantage over other enterococcal species in rat kidneys in a hematogenous inoculation pyelonephritis model ( 18). Another model system was used to show that pyelonephritis caused by Pseudomonas aeruginosa was aggravated by coinfection with E. faecalis, as determined by histological changes in the kidney ( 30). In this model, ligation of the urethra was used to induce retrograde reflux of bacteria into the kidney, increasing the susceptibility of the mouse to infection. In a bladder catheterization model of urinary tract infection, the Esp (enterococcal surface protein) adhesin was found to increase persistence in the urinary bladder of mice, although no histological changes were observed ( 26). Another study was unable to demonstrate a critical function for aggregation substance, a well-characterized enterococcal adhesin, in a murine model of cystitis ( 12). Thus, a robust murine cystitis model of E. faecalis infection has yet to be established, most likely due to complicating host and bacterial factors reflecting the adaptations enterococcus has evolved to coexist with its host. In order to more effectively devise strategies and therapies to prevent and treat enterococcal urinary tract infections, an infection model that can give a sensitive readout of virulence factors must be developed.

In contrast, many of the host-pathogen interactions critical for bladder infections caused by uropathogenic Escherichia coli, the most common etiologic agent of urinary tract infections, have been well-defined in murine models. Uropathogenic E. coli initially interacts with bladder epithelium through the expression of type 1 pili, which mediate adhesion and invasion into the uroplakin-expressing umbrella cells on the surface of the bladder ( 19). The invasion of E. coli into the urinary epithelium results in expression of a variety of cytokines, induction of apoptosis in infected cells, and a massive neutrophil inflammatory response. This response is mediated primarily by Toll-like receptor 4, which has been demonstrated to respond to lipopolysaccharide ( 22, 23). The interaction of E. coli with the mouse kidney epithelium during pyelonephritis is less well characterized, but the importance of P pili is well established as an initial mediator of adherence in other animal models ( 21). Similar to bladder infections, acute E. coli-mediated pyelonephritis in mice is characterized by a strong neutrophil immune response ( 4).

In this study, we describe the tropism of E. faecalis for the kidneys in C57BL/6J mice. The consequences of this tropism were investigated by characterizing the host response to E. faecalis and contrasting these differences to the response induced by uropathogenic E. coli.

MATERIALS AND METHODS

Strains and growth conditions.

A summary of all the strains used in this study, their origins, and relevant drug resistances are shown in Table . For infection of mice, E. faecalis strains were grown statically overnight (typically 12 to 15 h) at 37°C in brain heart infusion (BHI) medium (Difco) without antibiotics. Clinical strains other than 0852 were contributed by Thomas Hooten and Walter Stamm (University of Washington) and categorized as either cystitis or pyelonephritis strains using clinical criteria.

TABLE 1.

Animals.

Female wild-type C57BL/6 mice were obtained from Jackson Laboratories and C57BL/6 TLR2 −/− mice were a gift of S. Akira ( 29). TLR2 −/− mice were 36 to 48 weeks in age at the time of inoculation. Wild-type 12-week-old and 52-week-old mice were used to control for the various ages of the TLR2 −/− mice. These experiments demonstrated that there was no substantial difference in the recoveries of E. faecalis due to the ages of the mice. In all other experiments, mice were 8 to 12 weeks of age.

Inoculation and CFU enumeration.

Cultures were collected by centrifugation at ≈6,000 × g for 10 min and resuspended in phosphate-buffered saline (PBS) to an approximate density of 10 ⁷ to 10 ⁸ CFU/ml. Female C57BL/6J mice were anesthetized with inhaled isoflurane and then inoculated transurethrally with 200 μl of bacterial suspension similar to methods described in Schilling et al. ( 23). Although the inoculation volume of 200 μl resulted in leakage during and after inoculation, we found that this volume resulted in the most consistent infections.

At the appropriate time points, mice were sacrificed by cervical dislocation after inhalation anesthesia and the bladders and kidneys were harvested. For histologic evaluation, tissue was fixed in neutral buffered formalin and embedded in paraffin. To determine the number of bacteria present in these tissues, bladders or pairs of kidneys were homogenized in 0.025% Triton X-100 in PBS and plated at different dilutions on BHI agar (BactoAgar from BD) supplemented with antibiotics where appropriate. CFU were enumerated after 24 h of incubation at 37°C. Statistical analysis of the kinetic experiment was performed using Student's one-tailed t test for correlated samples using the logarithmic values at each time point. When the recovered titers were below the limit of detection, the recovered CFU value was set to 1 for statistical analysis.

Immunohistochemistry.

For immunohistochemical analysis of bladder tissue, 5-μm-thick sections were prepared. Sections were deparaffinized using Hemo De (Fisher) (twice for 10 min), rinsed with isopropanol (three times for 3 min) and washed with PBS (three times for 5 min). Tissue sections were blocked with 1% bovine serum albumin, 0.2% nonfat dry milk, and 0.3% Triton X-100 in PBS (PBS-BB) for 15 min at room temperature. Primary antibody raised in rabbit against Streptococcus group D antigen (Lee Laboratories) was added in PBS-BB and incubated overnight at 4°C. After PBS washings (three times for 5 min), tissue was incubated with Alexafluor 555-labeled donkey anti-rabbit antibody (Molecular Probes) in PBS-BB and incubated overnight at 4°C. After PBS washes (three times for 5 min), tissue was counterstained with bis-benzimide (Sigma) to reveal nuclear morphology.

Quantitative real-time PCR.

Methods were as described in Mysorekar et al. ( 20) with the following modifications. Female C57BL/6J mice were inoculated transurethrally with 200 μl of PBS, E. faecalis 0852, or uropathogenic E. coli isolate NU14 grown statically in Luria-Bertani (LB) for 48 h to induce type 1 pilus expression. At the time of sacrifice, kidneys were divided lengthwise, and one half was harvested for RNA isolation and the other half was titered to confirm the presence of bacteria. RNA from infected bladders and kidneys was collected either 6 h or 24 h after infection individually from each mouse using a commercially available affinity matrix-based kit (RNeasy kits, Qiagen). cDNA was generated using random hexamers and quantitative real-time PCR was performed as described ( 20) using the Bio-Rad iCycler. Primers for amplification of glyceraldehhyde-3-phosphate dehydrogenase, Mip-2, and Socs-3 are as previously described ( 20).

Competitive infection.

Cultures of OG1X and BP78 were resuspended in PBS and mixed in equal volumes to make the mixed inoculum. The BP78 to OG1X ratio was determined by plating the mixed inoculum on medium selective for each strain; 48 h after infection, mice were sacrificed and their bladders and kidneys were collected and homogenized as described above. The homogenate was then plated onto either BHI agar supplemented with streptomycin, to select for OG1X, or tetracycline, to select for BP78. The competition index was calculated similarly to Freter et al. using OG1X as the reference strain ( 3). Briefly, the competition index = [(CFU of BP78/CFU of OG1X recovered from mice)/(CFU of BP78/CFU of OG1X present in initial inoculum)].

RESULTS

E. faecalis can cause a reproducible infection in C57BL/6J mouse kidneys.

In order to study E. faecalis cystitis, we inoculated 50 μl of 10 ⁸ CFU of an E. faecalis strain, 0852, from a diagnosed urinary tract infection transurethrally into female C57BL/6J mice. This protocol led to inconsistent recovery of bacteria from the bladder but noticeably higher titers in the kidney. Based on this observation, we used a 200-μl inoculum volume to intentionally induce retrograde reflux of the inoculum from the bladder into the kidney ( 11).

The ability of E. faecalis 0852 to persist in bladders and kidneys over a 2-week period is shown in Fig. . Fifteen minutes after inoculation, bacterial titers were high in both the bladder and the kidney. E. faecalis did not persist in the bladder, as bacterial titers decreased dramatically after 15 min, and many bladders were sterile at later time points. In contrast, recovery of bacteria from the kidneys remained steady over the first 12 h; 24 h after inoculation, bacterial levels in the kidney decreased but nevertheless persisted over a 2-week period. The conclusion from these studies was that E. faecalis persisted at higher titers in the kidney than in the bladder over a 2-week time frame (Fig. , P < 0.05 for five of nine time points, P < 0.1 for eight of nine time points).

The large dropoff in bladder titers between 15 min and 6 h was most likely due to the clearance of nonadherent bacteria from the bladder by mechanical forces of urine flow and other innate defenses. The persistence of E. faecalis in the kidneys over this time period indicated that the bacteria in the kidney were able to establish residence capable of evading innate defenses. Consistent with this hypothesis was the finding that 16% of mice had recoverable titers of 0852 in the kidneys despite having sterile bladders; conversely, no mice had recoverable bacterial titers in the bladder if their kidneys were sterile (Fig. , squares). Given the variability of CFU per bladder, we hypothesized that bacteria recovered from the bladder at later time points may represent bacteria shed from the kidney. Taken together, the persistence of 0852 in the kidney and its clearance from the bladder suggest that E. faecalis has tropism for the kidneys in the urinary tract of C57BL/6J mice.

Multiple E. faecalis clinical isolates display tropism for the kidney in the urinary tract of C57BL/6J mice.

To determine if the tropism of E. faecalis for the kidney in C57BL/6J mice is specific to strain 0852 or whether it represents a general feature of this species, we inoculated mice with five different strains of E. faecalis and harvested their bladders and kidneys for titers 48 h after infection (Fig. ). Two of these strains, B1223 and B1384, were cystitis isolates, and three others, P1503, BP78, and BP250, were pyelonephritis isolates. Consistent with what had been observed with 0852, all of the strains persisted in the kidney to higher levels than in the bladder. Only three mice of the 29 in the group infected with cystitis-derived isolates had more bacteria in the bladder than in the kidney. While this finding may represent an adaptation of the cystitis isolates to have increased adherence to bladder epithelium, the kidney still appeared to have the larger bacterial burden in the majority of mice.

Transurethral inoculation of 0852 results in inflammation in the kidneys but not the bladder.

Kidneys and bladders were subjected to histological analysis at various time points following inoculation with E. faecalis 0852. Hematoxylin and eosin staining revealed that there was little difference between infected and uninfected bladders at any of the time points examined (6 h, 24 h, 2 days, and 4 days; 24-h time point shown in Fig. ). In contrast, E. coli induces cystitis, as measured by the disruption of the bladder epithelium, marked edema, and recruitment of numerous neutrophils at the same time point ( 4, 14, 19).

Kidney sections from E. faecalis-infected mice, however, showed an inflammatory infiltrate in the renal pelvis. The inflammation was most consistently evident at 24 h after inoculation but was also seen at other time points as small, isolated collections of inflammatory cells. The level of inflammation at 24 h in the kidney was variable, sometimes appearing quite extensive, with inflammatory cells lining the entire pelvis (Fig. ), but small, localized patches of inflammation were also observed along the pelvis (as in Fig. ). The cellular infiltrate in the kidneys is primarily monocytic, as determined by histologic features. This is in contrast to the mostly neutrophilic infiltrate seen in E. coli pyelonephritis ( 4). The results of the histologic analysis of the bladder and kidney demonstrate that E. faecalis can consistently cause pathology in the kidney but not the bladder, further confirming the tropism of E. faecalis for the mouse kidney.

Immunohistochemistry was also utilized to demonstrate the presence of enterococcal antigen within the infected kidney. Using the rabbit Lancefield group D antibody, we showed staining in association with areas of inflammation at 24 h postinfection, demonstrating that the inflammatory cells were recruited in response to the presence of E. faecalis rather than damage to the kidney parenchyma by the inoculation procedure (Fig. ).

Inflammatory markers induced by uropathogenic E. coli are not upregulated in the bladder in response to E. faecalis.

The interaction of uropathogenic E. coli with the bladder epithelium results in the expression of a variety of proteins involved in epithelial renewal and immune function ( 20). Among these, the proinflammatory marker Mip-2, the mouse orthologue to human interleukin-8, and Socs-3, a modulator of cytokine induction, were highly upregulated. We investigated whether E. faecalis induced a similar response in the urinary tracts of mice.

E. faecalis 0852- or sham-infected mouse bladders and kidneys were harvested 6 h or 24 h after inoculation, and RNA was collected in order to quantify the relative levels of Mip-2 and Socs-3 by quantitative reverse transcription-PCR. The relative induction of Mip-2 and Socs-3 after infection with NU14 (a clinical uropathogenic E. coli isolate) or E. faecalis 0852 was investigated (Fig. ); 24 h after infection with either E. coli NU14 or E. faecalis 0852, NU14 induced Mip-2 and Socs-3 176-fold and 15-fold, respectively, over E. faecalis in the bladder. In the kidney, Mip-2 and Socs-3 were also more strongly induced by E. coli NU14 but not to the same magnitude (24-fold greater induction of Mip-2 and 4-fold greater induction of Socs-3 at 6 h, when the differences were most pronounced). Detection of focal inflammation in the kidney caused by E. faecalis may be diluted in this assay, which surveys gene expression levels of the whole kidney. Regardless, the observation that the uropathogenic E. coli strain NU14 was a more potent inducer of inflammatory mediators in both the bladder and kidneys implies a distinct pathogenic mechanism for E. faecalis in the urinary tract.

Innate response to E. faecalis in the kidneys is TLR2 independent.

TLR4 has been demonstrated to be an important mediator of the innate host response to E. coli urinary tract infections ( 22, 23). TLR2 has been shown to mediate the host innate response to some gram-positive constituents such as lipoteichoic acid and peptidoglycan ( 24, 31). To determine if TLR2 plays a role in the initial response to E. faecalis, TLR2-deficient C57BL/6 were inoculated with 0852, and kidney titers were compared to wild-type mice 24 h after inoculation. There was no observable difference between the TLR2-deficient mice and the wild-type mice 24 h after infection, indicating that TLR2 did not play a critical role in the innate response (Fig. ). Histologic examination of TLR2 and wild-type C57BL/6J mice revealed no observable difference in the levels of inflammation between wild-type and mutant mice (data not shown).

Clinically derived E. faecalis has a survival advantage over OG1X in the kidneys of mice.

To assess the utility of mouse kidney infections as a model system to study pathogenesis of E. faecalis, the clinical strain BP78 and the laboratory strain OG1X were inoculated either separately or in a mixed suspension. As shown in Fig. , OG1X and BP78 colonized the bladders and kidneys of mice equally well when infected separately, as determined 48 h after infection. However, in the mixed-infection model, BP78 showed a competitive advantage over OG1X of approximately 10-fold in the kidney, but there was no discernible difference in the bladder (Fig. ).

DISCUSSION

Enterococci are usually perceived as commensal bacteria that coexist with their host under most circumstances as part of the normal flora. While not regarded as particularly virulent organisms, enterococci can be significant agents of urinary tract infections in the hospital setting, where patients' defenses can be compromised by catheterization, immune deficiencies, or both. Given that E. faecalis is an opportunistic pathogen, animal model systems to study ascending urinary tract infections have been difficult to develop but will be essential for understanding the molecular basis of enterococcal disease.

Two recent studies used an ascending model of urinary tract infections similar to that used for uropathogenic E. coli to investigate the function of the Esp and aggregation substance adhesins in the pathogenesis of E. faecalis urinary tract infection. A role for aggregation substance has not yet been elucidated, whereas mutations in esp reduced colonization of the bladder. An interesting caveat in these studies was that approximately 30% of the mice had sterile bladders even when challenged with wild-type E. faecalis ( 12, 26). These results highlight the need to elucidate the host-pathogen interactions required to maintain robust urinary tract infections with enterococci. Interestingly, both studies noted significant colonization of the kidney tissue despite using a volume of inoculum designed to deliver bacteria only to the bladder.

In the present study, we discovered that E. faecalis has tropism for the kidneys in female C57BL/6J mice. This finding was made using a model where the inoculation volume of E. faecalis was increased in order to facilitate direct delivery of the bacteria to both the bladder and the kidneys simultaneously. Using this technique, we were able to recover bacteria from >90% of kidneys in mice infected with E. faecalis. In the same mice, the bladders were frequently sterile even though the kidneys were colonized. The molecular basis of this tropism for the kidney is unknown. Preferential adherence and/or invasion of E. faecalis to kidney versus bladder epithelium is a potential explanation, but host factors involved in innate defenses may also play a role.

The use of cultured bladder cells to study enterococcal pathogenesis in the urinary tract has limitations. Superficial umbrella cells lining the lumen of the bladder have specialized properties, including an ability to assemble uroplakins on their surface. Uroplakins form impermeable plaques that coat the luminal surface of the bladder ( 15). Cultured epithelial cells are not terminally differentiated, do not assemble uroplakins into plaques, and lack other distinguishing features of superficial umbrella cells, such as their large surface area and pentagonal shape ( 27). Thus, tropism is best studied in an animal model such as the one described here.

E. faecalis-mediated urinary tract infection appears to occur via a strikingly different mechanism than E. coli-mediated urinary tract infection. In a typical E. coli urinary tract infection, the bacteria invade the superficial umbrella cells and replicate to high levels, forming intracellular biofilms, a process that induces a TLR4-mediated cytokine response that recruits neutrophils to the site of infection ( 1, 22). In enterococcal urinary tract infection, there is little to no inflammation in the bladder. Furthermore, neutrophils represented only a minority of the inflammatory cells targeted to the site of infection, which typically is in the kidney. We found that TLR2, which is hypothesized to play a similar role in the innate response to gram-positives as TLR4 does for gram-negative pathogens ( 28, 29), does not play a substantial role in the innate response to E. faecalis in the urinary tract. Several observations reinforce this hypothesis. The presence or absence of TLR2 had no significant impact on the recovery of E. faecalis 24 h after infection. A luciferase reporter cell line expressing TLR2 was not stimulated by enterococci ( 32). Finally, there is substantial evidence that the host uses TLR2-independent pathways to stimulate inflammatory cascades in response to gram-positive infection ( 2, 5, 17). The recent discovery of TLR11, a Toll-like receptor that specifically recognizes uropathogens, suggested an additional innate mechanism used by the host to respond to enterococci ( 32).

All six E. faecalis strains tested in this study demonstrated the same tropism for the kidney, suggesting that most E. faecalis strains contain the core set of virulence factors necessary to cause disease in the kidney. When inoculated separately, OG1X, a commonly used laboratory strain of E. faecalis that lacks the recently described enterococcal pathogenicity island ( 25) and plasmid elements, and BP78, a clinical pyelonephritis isolate, persisted at similar levels over a 48-h period. This implies that OG1X has the essential molecular elements necessary to persist in the kidney. However, in a mixed-competition experiment, BP78 had a survival advantage of approximately 10-fold, suggesting that uropathogenic E. faecalis isolates have additional factors that lead to increased fitness in the urinary tract. Thus, mixed-infection experiments proved to be the most sensitive readout of additional virulence factors that enhance persistence in the kidney.

This work raises numerous questions related to human disease. The ability of enterococci to cause disease in the kidney is well established. The diagnosis of upper versus lower urinary tract infection caused by enterococci, as with gram-negative bacilli, is generally based on signs and symptoms. Thus, the presence of fever and flank pain, with or without lower tract symptoms of dysuria, frequency, and urgency suggest upper tract infection ( 13). Lower tract symptoms without upper tract symptoms are assumed to represent bladder infection, although it has been reported that about 30% of women with symptoms of bladder infection have silent upper tract infection ( 13). It will be important to determine whether the findings described in this work can be extended to humans. If enterococci have a strong tropism for the kidney, it is possible that many or most episodes of enterococcal cystitis are due to seeding from an upper tract infection. It is also possible that asymptomatic bacteriuria with enterococci is often localized to the upper tract rather than the bladder. The observation that enterococci fail to elicit a strong induction of inflammatory cytokines in our murine model is consistent with this hypothesis. If enterococcal urinary tract infections are often associated with upper tract infection, there may be treatment implications, since upper tract infection is usually treated for a longer duration than bladder infections ( 6).

Acknowledgments

We thank members of the Hultgren laboratory for reading the manuscript, T. Hooten and W. Stamm for providing clinical strains, and S. Akira for TLR2-deficient mice.

This work was supported by National Institutes of Health and Office of Research on Women's Health Specialized Center of Research P50DK6454002 with the Food and Drug Administration (to S.J.H.), NIH grant AI-38273 (M.G.C.), Individual National Research Service Award F32DK06388702 (to S.M.), Pediatric Physician-Scientist Training Grant 5T32HD4301003 (E.H.), and Medical Scientist Training Program grant T32 GM07200 (A.K.).

Notes

Editor: A. D. O'Brien

REFERENCES

3. [[ Freter, R., P. C. O'Brien, and M. S. Macsai. 1981. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect. Immun. 34 :234-240. PubMed] PMC free article] [ Google Scholar]

8. [[ Huycke, M. M., D. F. Sahm, and M. S. Gilmore. 1998. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4 :239-249. PubMed] PMC free article] [ Google Scholar]

9. [[ Ike, Y., D. B. Clewell, R. A. Segarra, and M. S. Gilmore. 1990. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn 917 insertional mutagenesis and cloning. J. Bacteriol. 172 :155-163. PubMed] PMC free article] [ Google Scholar]

17. [[ Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100 :1966-1971. PubMed] PMC free article] [ Google Scholar]

30. [[ Tsuchimori, N., R. Hayashi, A. Shino, T. Yamazaki, and K. Okonogi. 1994. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice. Infect. Immun. 62 :4534-4541. PubMed] PMC free article] [ Google Scholar]

# data[].attributes.attachment_link.title
Enterococcus faecalis Tropism for the Kidneys in the Urinary Tract of C57BL/6J Mice

# data[].attributes.attachment_link.description
Enterococcus faecalis is a gram-positive bacterium that can cause a variety of nosocomial infections of which urinary tract infections are the most common. These infections can be exceptionally difficult to treat because of drug resistance of many E. faecalis isolates. Despite their troublesome nature, little is known about the host or bacterial factors necessary for E.

# data[].attributes.body
As seen here for Tree 13, Tannerella forsythia is the most closely related and Streptococcus gordonii is the most distant cousin. This means Streptococcus gordonii changed before all of the other cousins.

# data[].attributes.headline
Step 8: New Research for Enterococcus faecalis 

# data[].attributes.subject
Step 8: New Research for Enterococcus faecalis 

# data[].attributes.body
Enterococcus faecalis has shown virulences genes and considerable amount of antibiotic resistance, which is very alarming.

# data[].attributes.attachment_link.readable_text
Affiliations

¹ 1 Infectious and Tropical Diseases Research Centre, Tabriz University of Medical Sciences , Tabriz, Iran .

² 2 Department of Clinical Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran .

³ 3 Department of Clinical Microbiology, Faculty of Medicine, Urmia University of Medical Sciences , Urmia, Iran .

⁴ 4 Department of Medical Genetics, Motahari Teaching Hospital, Urmia University of Medical Sciences , Urmia, Iran .

⁵ 5 Department of Microbiology, School of Medicine, Gonabad University of Medical Sciences , Gonabad, Iran .

Affiliations

¹ 1 Infectious and Tropical Diseases Research Centre, Tabriz University of Medical Sciences , Tabriz, Iran .

² 2 Department of Clinical Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran .

³ 3 Department of Clinical Microbiology, Faculty of Medicine, Urmia University of Medical Sciences , Urmia, Iran .

⁴ 4 Department of Medical Genetics, Motahari Teaching Hospital, Urmia University of Medical Sciences , Urmia, Iran .

⁵ 5 Department of Microbiology, School of Medicine, Gonabad University of Medical Sciences , Gonabad, Iran .

Abstract

The aim of this study was to characterize virulence determinants and antibiotic resistance profiles in enterococci obtained from various clinical sources in the northwest of Iran. A total of 160 enterococcal clinical isolates from various wards of University Teaching Hospitals were collected and specified by biochemical test, from September 2014 to July 2015. Identification of enterococci was confirmed by multiplex PCR in the genus and species level. Antibiotic resistance properties and virulence determinants were examined by phenotypic and molecular methods. Of 160 enterococcal isolates, 125 (78.12%) and 35 (21.88%) isolates were identified as Enterococcus faecalis and Enterococcus faecium, respectively. The most common antibiotic nonsusceptible pattern observed was resistance toward rifampicin [n = 122 (76.25%)] followed by erythromycin [n = 117 (73.12%)]. Among all isolates, gelE [n = 140 (87.5%)], cpd [n = 137 (85.6%)], and asa1 [n = 118 (73.8%)] were the most prevalent virulence genes studied. Thirty isolates (11 E. faecalis, 19 E. faecium) were found to be resistant to vancomycin, with minimum inhibitory concentration of ≥256 μg/ml. Twenty-seven isolates carried the vanA gene, whereas none of the isolates carried vanB. E. faecalis had a considerable ability to show virulence genes and drug resistance. Emergence of antibiotic-resistant enterococci and the high prevalence of virulence traits in our study could be regarded as an alarming situation.

Keywords: E. faecalis; E. faecium; antibiotic resistance; virulence factors.

# data[].attributes.attachment_link.keywords[]
enterococcus faecalis / isolation & purification

# data[].attributes.attachment_link.keywords[]
enterococcus faecium / isolation & purification

# data[].attributes.attachment_link.keywords[]
gram-positive bacterial infections / drug therapy

# data[].attributes.attachment_link.keywords[]
national center for biotechnology information

# data[].attributes.attachment_link.title
Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants - PubMed

# data[].attributes.attachment_link.description
The aim of this study was to characterize virulence determinants and antibiotic resistance profiles in enterococci obtained from various clinical sources in the northwest of Iran. A total of 160 enterococcal clinical isolates from various wards of University Teaching Hospitals were collected and spe ...

# data[].attributes.headline
Step 1: Organism 1 Source Page & Picture (All from same Link)

# data[].attributes.subject
Step 1: Organism 1 Source Page & Picture (All from same Link)

# data[].attributes.body
- "Gemella haemolysans is a Gram-positive coccoid, catalase-negative, facultative anaerobic microorganism of the mucus membranes in humans."
- Figure below shows subacute endocarditis caused by Gemella haemolysans.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016745/#:~:text=Gemella%20haemolysans%20is%20a%20Gram,emerging%20bacterial%20etiology%20in%20IE.